Literature DB >> 3893569

Phenotypic heterogeneity among stromal cell lines from mouse bone marrow disclosed in their extracellular matrix composition and interactions with normal and leukemic cells.

D Zipori, J Toledo, K von der Mark.   

Abstract

Study of a series of stromal cell lines from mouse bone marrow (MBA) verified and extended their classification as phenotypically distinct subtypes. Production of extracellular matrix proteins was examined using specific antibodies. Fibronectin and laminin were detected in all of the cell lines tested, yet 14F1.1 adipocytes exhibited particularly prominent extracellular deposition. This cell line and MBA-13.2 cells were positive to both collagen types I and IV, whereas MBA-1 and MBA-2.1 were stained with anticollagen type I antibodies only. Coculture experiments revealed differences among the lines in their effects on normal myeloid cells and leukemic cell lines. In promoting the in vitro accumulation of myeloid progenitors (CFU-C), 14F1.1 cells surpassed the others. The MBA-2.1 cell line was particularly inhibitory to MPC-11 plasmacytoma and Friend erythroleukemia cells. However, the latter were refractory to other stromal cell lines, whereas MPC-11 cells were inhibited to various degrees by virtually all of the cell lines. Physical separation between the interacting cells reduced the inhibition in some but not all cases, and no inhibitory activity was detected in conditioned media. The MBA-13 stromal cells synergistically promoted the differentiation of dimethylsulfoxide (Me2SO)-induced Friend erythroleukemia. The latter cells themselves, at high concentrations, as well as some of the stromal cell lines and unrelated adherent cells, antagonized the Me2SO effect, revealing possible reversible stages in the Friend cell differentiation pathway.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3893569

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  14 in total

1.  Induction of the chemokine stromal-derived factor-1 following DNA damage improves human stem cell function.

Authors:  T Ponomaryov; A Peled; I Petit; R S Taichman; L Habler; J Sandbank; F Arenzana-Seisdedos; A Magerus; A Caruz; N Fujii; A Nagler; M Lahav; M Szyper-Kravitz; D Zipori; T Lapidot
Journal:  J Clin Invest       Date:  2000-12       Impact factor: 14.808

2.  Recent studies of the hematopoietic microenvironment in long-term bone marrow cultures.

Authors:  J S Greenberger; T J FitzGerald; P Anklesaria
Journal:  Immunol Res       Date:  1989       Impact factor: 2.829

3.  Subpopulations of marrow stromal cells share a variety of osteoblastic markers.

Authors:  D Benayahu; A Fried; D Zipori; S Wientroub
Journal:  Calcif Tissue Int       Date:  1991-09       Impact factor: 4.333

Review 4.  The origins of mesenchymal stromal cell heterogeneity.

Authors:  Meirav Pevsner-Fischer; Sarit Levin; Dov Zipori
Journal:  Stem Cell Rev Rep       Date:  2011-09       Impact factor: 5.739

5.  Dual Effects of Melanoma Cell-derived Factors on Bone Marrow Adipocytes Differentiation.

Authors:  Juan Wang; Jin Wen; Xiao-Xiang Chen; Guang-Liang Chen
Journal:  J Vis Exp       Date:  2018-08-23       Impact factor: 1.355

6.  Immunochemical characterization and ultrastructural localization of chondroitin sulfates and keratan sulfate in embryonic chick bone marrow.

Authors:  J M Sorrell; F Mahmoodian; B Caterson
Journal:  Cell Tissue Res       Date:  1988-06       Impact factor: 5.249

7.  Differentiation of the rat myelomonocytic leukemia cell line c-WRT-7 by in vitro culture with the rat bone marrow preadipocyte cell line REC A16.

Authors:  T Tanaka; S Okamura; S Yasumoto; N Takeichi; H Kobayashi; Y Niho
Journal:  J Cancer Res Clin Oncol       Date:  1993       Impact factor: 4.553

8.  17 beta-estradiol inhibits interleukin-6 production by bone marrow-derived stromal cells and osteoblasts in vitro: a potential mechanism for the antiosteoporotic effect of estrogens.

Authors:  G Girasole; R L Jilka; G Passeri; S Boswell; G Boder; D C Williams; S C Manolagas
Journal:  J Clin Invest       Date:  1992-03       Impact factor: 14.808

9.  Detection of receptors for interleukin-6, interleukin-11, leukemia inhibitory factor, oncostatin M, and ciliary neurotrophic factor in bone marrow stromal/osteoblastic cells.

Authors:  T Bellido; N Stahl; T J Farruggella; V Borba; G D Yancopoulos; S C Manolagas
Journal:  J Clin Invest       Date:  1996-01-15       Impact factor: 14.808

10.  Microglia and microglia-like cell differentiated from DC inhibit CD4 T cell proliferation.

Authors:  Bo Bai; Wengang Song; Yewei Ji; Xi Liu; Lei Tian; Chao Wang; Dongwei Chen; Xiaoning Zhang; Minghui Zhang
Journal:  PLoS One       Date:  2009-11-17       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.